ATP-sensitive potassium channel openers for the treatment of coronary atherosclerotic heart disease: a medical records based Real World Study

ATP-sensitive potassium channel openers for the treatment of coronary atherosclerotic heart disease Real World Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027812

Enrollment

Unknown

Registered

2019-11-29

Start date

2020-01-01

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary atherosclerotic heart disease

Interventions

ATP group VS non-ATP group:non-intervention

Sponsors

Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology

Lead Sponsor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Clinical diagnosis of CVD patient or the patient diagnosed with Coronary angiography evidence; 2. Aged >18 years old.

Exclusion criteria

Exclusion criteria: Important demography information, or electronic medical record information is wrong or missing seriously

Design outcomes

Primary

Measure	Time frame
major adverse cardiovascular events, MACE;	—

Secondary

Measure	Time frame
Demography information;Risk factors related to CAD;average dosage of ATP K treatment, and treatment duration;The proportion of abnormal finding in echocardiogram;the proportion of anti-ischemic treatment apply and average dosage;	—

Countries

China

Contacts

Public ContactZhou Ning

Section of cardiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology

zhouning@tjh.tjmu.edu.cn+86 13871249571

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 16, 2026